Nuclear Medicine Market in US by 2026 | Global Forecast, Trends, Opportunity and Industry Analysis

The Global report on “Nuclear Medicine Market in US” delivering key insights and providing a competitive advantage to clients through a detailed report. The report also details the information about the global market status, growth rate, future trends, market drivers, challenges, opportunities and porter’s forces analysis with respect to these elements. An exclusive data offered in this report is collected by research and industry experts team.

Get Free Sample Research Copy @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=3303682

Nuclear Medicine,or Radiopharmaceuticals, are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

This report contains market size and forecasts of Nuclear Medicine in US, including the following market information:
US Nuclear Medicine Market Revenue, 2015-2020, 2021-2026, ($ millions)
Top Five Competitors in US Nuclear Medicine Market 2019 (%)

The global Nuclear Medicine market was valued at 5490.7 million in 2019 and is projected to reach US$ 7219.3 million by 2026, at a CAGR of 7.1% during the forecast period. While the Nuclear Medicine market size in US was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
COVID-19 pandemic has big impact on Nuclear Medicine businesses, with lots of challenges and uncertainty faced by many players of Nuclear Medicine in US. This report also analyses and evaluates the COVID-19 impact on Nuclear Medicine market size in 2020 and the next few years in US

Total Market by Segment:
US Nuclear Medicine Market, By Type, 2015-2020, 2021-2026 ($ millions)
US Nuclear Medicine Market Segment Percentages, By Type, 2019 (%)
– Tc-99
– I-123/131
– In-111
– Xe-133
– Th-201
– Ga-67
– Other

US Nuclear Medicine Market, By Application, 2015-2020, 2021-2026 ($ millions)
US Nuclear Medicine Market Segment Percentages, By Application, 2019 (%)
– Diagnostic
– Therapeutic

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Nuclear Medicine Market Competitors Revenues in US, by Players 2015-2020 (Estimated), ($ millions)
Total Nuclear Medicine Market Competitors Revenues Share in US, by Players 2019 (%)

Further, the report presents profiles of competitors in the market, including the following:
– GE Healthcare
– Bracco Imaging
– Mallinckrodt
– Lantheus Medical Imaging
– Bayer
– Triad Isotopes
– Nordion
– Jubilant Pharma
– Eli Lilly
– SIEMENS
– China Isotope & Radiation

More information about Discount offers (20% or More)  @ https://www.reportsnreports.com/contacts/discount.aspx?name=3303682

About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
We provide 24/7 online and offline support to our customers.

E-mail: [email protected]

Phone: +1 888 391 5441

Share This Post

Post Comment